Noah L. Rosenberg - Jul 28, 2021 Form 4 Insider Report for Travere Therapeutics, Inc. (TVTX)

Role
Chief Medical Officer
Signature
/s/ Elizabeth E. Reed, Attorney-in-Fact
Stock symbol
TVTX
Transactions as of
Jul 28, 2021
Transactions value $
-$17,263
Form type
4
Date filed
7/29/2021, 04:09 PM
Previous filing
May 13, 2021
Next filing
Aug 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TVTX Common Stock Sale -$17.3K -1.25K -2.73% $13.81 44.5K Jul 28, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported were made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.
F2 Includes 177 shares of the Issuer's common stock acquired by the reporting person on May 31, 2021 pursuant to an employee stock purchase program.